Elena Lara Jimenez

• Contributed to a study that identified the lncRNA ROSALIND as a key player in protecting mitochondrial ribosomes from oxidative damage in drug-tolerant cancer cells.
  
• Confirmed ROSALIND's subcellular localization. Additionally, demonstrated its therapeutic potential by inhibiting and overexpressing ROSALIND in various melanoma cell lines, and revealed its impact on cell growth and ROS levels.

• Completed three 5-week internships, gaining hands-on experience with various laboratory techniques:

1. Laboratory of Behavioral and Developmental Genetics:

• Researched microbiome-dependent transporters in Drosophila.
• Studied the role of CNVs in developmental disorders through chromatin topology alterations.

2. Laboratory for Mechanisms of Cell Transformation:

• Investigated targeting OTUB1 for lung cancer therapy.
  
  

• Contributed to a study comparing the metabolic and vascular responses of Siberian and Western European adults to cold exposure, aiming to unravel population differences and implications for obesity and type 2 diabetes.
• Led data analysis corrections, conducted pilot tests, recruited participants, and performed comprehensive measurements of Western European adults.